New hope for gout sufferers: drug trial targets those failed by current meds
Disease control
Not yet recruiting
This study tests a new drug called dotinurad for adults with gout who cannot take common medications or have not responded to other treatments. The goal is to see if dotinurad can safely lower uric acid levels in the blood. About 90 participants will receive either the drug or a …
Phase: PHASE2 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:17 UTC